✦ LIBER ✦

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis

✍ Scribed by Miyake, Tomohiro; Ito, Takashi; Yanai, Ayako; Inoue, Natsuko; Miyagawa, Yoshimasa; Murase, Keiko; Imamura, Michiko; Ichii, Shigetoshi; Takatsuka, Yuichi; Nishizaki, Tomoyuki; Hirota, Seiichi; Ohtsuka, Masahisa; Yamamoto, Hirofumi; Noguchi, Shinzaburo; Miyoshi, Yasuo

Book ID: 120959174
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 407 KB
Volume: 22
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-013-0487-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB-2 (HER-2/neu) gene amplification

c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients

✍ Guy Riou; Marie-Christine Mathieu; Michel Barrois; Marie-Luce Le Bihan; Jean-Cha 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB 👁 2 views

Cytoplasmic Poly(A) Binding Protein 4 Is

Cytoplasmic Poly(A) Binding Protein 4 Is Highly Expressed in Human Colorectal Cancer and Correlates with Better Prognosis

✍ Liu, Dan; Yin, Bin; Wang, Qiang; Ju, Wenyi; Chen, Yuanjia; Qiu, Huizhong; Li, Ji 📂 Article 📅 2012 🏛 Elsevier 🌐 Chinese ⚖ 808 KB

Decreased Survival of Human Breast Cance

Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg

✍ Fuenmayor, J.; Perez-Vazquez, K.; Perez-Witzke, D.; Penichet, M. L.; Montano, R. 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 367 KB

CYP3A4, CYP2C9 and CYP2B6 expression and

CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes

✍ Schmidt, R; Baumann, F; Knüpfer, H; Brauckhoff, M; Horn, L-C; Schönfelder, M; Kö 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Bridge-1 is expressed in human breast ca

Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line

✍ Constanze Banz-Jansen; Birte Münchow; Klaus Diedrich; Dominique Finas 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 657 KB

Treatment with trastuzumab for 1 year af

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB